[1]
H. H. MUTLU, “DETERMİNATİON OF NEUROPATHY DEVELOPMENT IN EARLY PERIOD IN METABOLIC SYNDROME AND TYPE 2 DIABETIC PATIENTS”, Ejons J., vol. 4, no. 14, pp. 284–292, Jun. 2020.